Skip to main content
Izotropic Corporation logo

Izotropic Corporation — Investor Relations & Filings

Ticker · IZO ISIN · CA46604F1099 LEI · 529900IZ5PIVM7X6S027 CSE Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2025-05-17 Regulatory Filings
Country CA Canada
Listing CSE IZO

About Izotropic Corporation

https://izocorp.com/

Izotropic Corporation develops and commercializes diagnostic medical devices, specializing in advanced breast cancer detection technology. Its flagship product is IzoView, a dedicated Breast CT imaging platform. IzoView utilizes high-resolution, true 3D imaging without requiring breast compression, offering superior spatial resolution compared to traditional modalities. The system is purpose-built to improve diagnostic accuracy and patient comfort, particularly targeting the 50% of women with dense breast tissue where conventional screening tools are often inadequate. Izotropic is currently advancing IzoView through pivotal clinical studies toward product launch and commercialization.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2025-05-17 English
News release - English.pdf
Capital/Financing Update Classification · 72% confidence The document is a corporate press release announcing multiple corporate actions: engaging an international communications consultant, granting incentive stock options and restricted share units (equity awards) to directors and consultants, and amending a promissory note agreement (including bonus warrants issuance) with the primary lender. These actions constitute updates to the company’s financing arrangements and capital structure (debt amendments, warrants, and equity awards). Therefore, the filing most closely aligns with a Capital/Financing Update (CAP).
2025-04-02 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 85% confidence The document is a Form 52-109FV2 certification by the CFO of interim filings (Interim Financial Report and Interim MD&A) under Canadian securities rules. It is not the interim report itself (IR) but a regulatory compliance certificate required to be filed. There is no announcement of an AGM, no management change, no financing, no earnings release, etc. Therefore it best fits the general Regulatory Filings fallback category (RNS).
2025-04-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 78% confidence The document is a NI 52-109 Form 52-109FV2 “Venture Issuer Basic Certificate” certifying review and fair presentation of interim filings. It is not the interim financial report or MD&A itself but a certification form filed with regulators. It does not announce a dividend, financing, board change, or present earnings, nor is it the report publication notice of the interim filings; rather it is a required regulatory certification. This does not map to any specific category like IR or MDA, so it falls under the fallback “Regulatory Filings” category.
2025-04-01 English
Interim MD&A - English.pdf
Management Reports Classification · 93% confidence The document is titled “Management’s Discussion and Analysis” (MD&A) for the nine months ended January 31, 2025 and contains management’s review of interim results under IAS 34. It is not a full annual report or one‐page factsheet; it is the detailed narrative explanation of financial performance, trends, outlook, and key developments—i.e., Management Reports (MDA).
2025-04-01 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Consolidated Financial Statements (Unaudited)' for the three and nine months ended January 31, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Comprehensive Loss, Statement of Changes in Shareholders' Equity, and Statement of Cash Flows) along with detailed explanatory notes. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. 9M 2025
2025-04-01 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.